Viewing Study NCT01796366


Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2025-12-29 @ 11:26 PM
Study NCT ID: NCT01796366
Status: COMPLETED
Last Update Posted: 2017-03-01
First Post: 2013-02-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module